Karishma Khullar, MD

Radiation Oncology
Accepting new patients
Sees patients age 18 and up
Penn Radiation Oncology Perelman - 2nd Floor
Make an appointmentCall 800-789-7366
Headshot of Karishma Khullar, MD
Penn Medicine Provider

About me

  • Assistant Professor of Clinical Radiation Oncology

My education and training

  • Medical School: University of Cincinnati College of Medicine

Spoken languages

English
English
हिन्दी
Hindi

Insurance accepted

Please contact the practice and/or the member services department of your insurance company for specific details before receiving services. Providers may participate in some, but not all, products offered by a health plan; providers may also accept plans at some practice locations but not others.

Locations

Penn Medicine hospital privileges

  • Hospital of the University of Pennsylvania: Has privileges to treat patients in the hospital.
  • Penn Presbyterian Medical Center: Has privileges to treat patients in the hospital.
Dr. Khullar is a Penn Medicine physician.

Qualifications and experience

Treatments and conditions

Research

Publications

J Fu, A Pepin, C Hollawell, S Appel, K Tang, J S Bryer, A Munter, R Maxwell, A Lin, S Feigenberg, J Bradley, W Levin, K Khullar, J Metz, J P Plastaras, A Goel Feasibility and Baseline Characteristics in a Phase II Single Institution Continuous Activity Monitoring (CAM 2.0) Trial for Patients Undergoing Chemoradiation , ACRO 2026 Summit: 2026

Perlow HK, Khullar K, Kumar R, Sasmal S, Nakamoto K, Gokun Y, Eckstein J, Young R, Diaz DA, Martin D, et al Evaluating the Impact of Common Non-Oncologic Medication Use During Radiotherapy in Patients with High-Risk Prostate Cancer. , Current Oncology , 32(6): 2025,353

Khullar K, Deek RA, Nelson B, Gaines D, Corrigan KL, LeCompte MC, Deville C Jr, Deek MP, Jabbour SK. Gender and the Receipt of the Association of Residents in Radiation Oncology Educator of the Year Award , Adv Radiat Oncol, 9(1): 2023,101305

Khullar K, Plascak JJ, Parikh RR Acute lymphoblastic leukemia (ALL) in adults: disparities in treatment intervention based on access to treatment facility , Leukemia & Lymphoma, 63(1): 2021,170-178

Khullar K, Hanft S, Mehnert JM, Weiner JP Complete response of brainstem metastasis in BRAF-mutated melanoma without stereotactic radiosurgery after initiation of encorafenib and binimetinib , Melanoma Res, 31(4): 2021,393-396

Modi C, Dragun AE, Henson CF, Jain S, Ahlawat S, Eastwick G, Kubicek GJ, Mezera M, Mulvihill DJ, Perri J, Juneja B, Khullar K, Ennis RD, Haffty BG A Statewide Multi-Institutional Study of Asymptomatic Pretreatment Testing of Radiation Therapy Patients for SARS-CoV-2 in a High-Incidence Region of the United States , Adv Radiat Oncol, 6(4): 2021,100704

Khullar K, Dhawan ST, Nosher J, Jabbour SK Fiducial marker migration following computed tomography-guided placement in the liver: a case report , AME Case Reports, 5: 2021,15

Khullar K & Parikh RR The role of radiotherapy in metastatic prostate cancer , Am J Clin Exp Urol, 7(2): 2021,92-97

Khullar K, Plasack JJ, Drachtman R, Cole PD, Parikh RR Associations between race and survival in pediatric patients with diffuse large B-cell lymphoma , Cancer Medicine, 10(4): 2021,1327-1334

Wang SJ, Khullar K, Kim S, Crayton SH, Yegya-Raman N, Groisberg R, Silk AW, Nosher JL, Malhotra J, Gentile MA, Mehnert JM, Jabbour SK. Cyclooxygenase inhibitor use during checkpoint immunotherapy and effect on time to progression and overall survival for metastatic melanoma and non-small cell lung cancer patients. , Journal for ImmunoTherapy of Cancer: 2020